FDA Submits Proposed Information Collection for Adverse Event Reporting Guidance

Summary

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance, focusing on adverse event reporting for outsourcing facilities under the Federal Food, Drug, and Cosmetic Act, specifically Section 503B.